Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.63 |
| ▸ | PAM | P19021 | 2/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.54 |
| ▸ | PPARG | P37231 | 7/20 | 0.54 |
| ▸ | PPARD | Q03181 | 7/20 | 0.54 |
| ▸ | PPARA | Q07869 | 7/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 5/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | FABP4 | P15090 | 2/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | PDE4A | P27815 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27586249 | 0.98 | DGKA (0.67) | DGKAPAMAKR1B1GPR84PPARG | |
| SCHEMBL3446796 | 0.98 | DGKA (0.67) | DGKAPAMAKR1B1GPR84PPARG | |
| SCHEMBL3447479 | 0.98 | DGKA (0.67) | DGKAPAMAKR1B1GPR84PPARG | |
| SCHEMBL4994992 | 0.98 | DGKA (0.67) | DGKAPAMAKR1B1GPR84PPARG | |
| SCHEMBL3446767 | 0.98 | DGKA (0.67) | DGKAPAMAKR1B1GPR84PPARG | |
| Hexanoate SCHEMBL7031339 | 0.96 | DGKA (0.70) | DGKAPAMAKR1B1GPR84PPARG | |
| Acetic Acid SCHEMBL28276583 | 0.96 | DGKA (0.59) | DGKAPAMAKR1B1GPR84PPARG | |
| SCHEMBL19639 | 0.96 | DGKA (0.57) | DGKAPAMAKR1B1GPR84PPARG | |
| Decanoic Acid SCHEMBL25235181 | 0.94 | DGKA (0.74) | DGKAPAMAKR1B1GPR84PPARG | |
| Heptanoate SCHEMBL28181115 | 0.94 | DGKA (0.74) | DGKAPAMAKR1B1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117050792-A | Diesel antiwear agent composition, preparation method thereof and diesel oil composition | 中国石油化工股份有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-113462442-B | Diesel antiwear agent composition, preparation method thereof and diesel oil composition | 中国石油化工股份有限公司 | 2023-06-09 | — | — | CN | claimed |
| CN-110621808-B | Aqueous treatment liquid, chemical conversion treatment method, and chemical conversion treated steel sheet | 日铁日新制钢株式会社 | 2022-07-08 | — | — | CN | claimed |
| US-11280004-B2 | Water-based treatment solution, chemical conversion treatment method, and chemical-conversion-treated steel sheet | NIPPON STEEL NISSHIN CO., LTD. (JP) | 2022-03-22 | — | — | US | claimed |
| CN-113462442-A | Diesel antiwear agent composition, preparation method thereof and diesel composition | 中国石油化工股份有限公司 | 2021-10-01 | — | — | CN | claimed |
| CN-111850596-B | Continuous production method for electrochemically synthesizing sebacate compounds | 万华化学(四川)有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-111850596-A | Continuous production method for electrochemically synthesizing sebacate compounds | 万华化学集团股份有限公司 | 2020-10-30 | — | — | CN | claimed |
| CN-110621808-A | Aqueous treatment liquid, chemical conversion treatment method, and chemical conversion treated steel sheet | 日铁日新制钢株式会社 | 2019-12-27 | — | — | CN | claimed |
| US-20170001944-A1 | CHEMICAL PROCESS TO CONVERT MUCIC ACID TO ADIPIC ACID | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-01-05 | — | — | US | claimed |
| WO-2015084265-A1 | CHEMICAL PROCESS TO CONVERT MUCIC ACID TO ADIPIC ACID | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-06-11 | — | — | WO | claimed |
| US-7060301-B2 | In situ mono-or diester dicarboxylate compositions | ECOLAB INC. (US) | 2006-06-13 | — | — | US | claimed |
| CN-1678961-A | Removing solution | DAIKIN IND LTD (JP) | 2005-10-05 | — | — | CN | claimed |
| EP-1536291-A1 | REMOVING SOLUTION | Daikin Industries, Ltd. (JP) | 2005-06-01 | — | — | EP | claimed |
| US-6607618-B1 | Munitions propellant. The propellant has a nitrocellulose component is about fifty-two percent (52.0%) of the propellant. This is either a nitrocellulose having twelve and six-tenths percent (12.6%) nitrogen, or a combination of a | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2003-08-19 | — | — | US | claimed |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | ECOLAB USA INC. | 2003-01-30 | — | — | US | claimed |
| WO-2003005818-A1 | IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS | ECOLAB INC. (US) | 2003-01-23 | — | — | WO | claimed |
| EP-0410348-A1 | Topical spironolactone composition | G.D. Searle & Co. (US) | 1991-01-30 | — | — | EP | claimed |
| EP-0026982-A1 | Coating compositions containing mono- or diester coalescing agents and a substrate coated therewith | ROHM AND HAAS COMPANY (US) | 1981-04-15 | — | — | EP | claimed |
| US-4102953-A | Method for making extruded, solventless, composite-modified double base propellant | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1978-07-25 | — | — | US | claimed |
| US-3989776-A | Process for preparing double base propellants containing ballistic modifier | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1976-11-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170001944-A1 | CHEMICAL PROCESS TO CONVERT MUCIC ACID TO ADIPIC ACID | MUC1, ADIPOR1, FASN | DGKA 366/4885PAM 10/4885AKR1B1 676/4885 |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | DDC, HCAR3, ACMSD | DGKA 109/4885PAM 729/4885AKR1B1 848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.